CTEC.L vs RMD
CTEC.L: Convatec is a specialist medical technology company providing life-improving solutions for wound, ostomy, continence, and infusion care. RMD: ResMed develops cloud-connected software platforms and digital devices for out-of-hospital care, spanning sleep apnea management, COPD treatment, and residential care operations.
Side-by-side fundamentals
| Metric | CTEC.L | RMD | Edge |
|---|---|---|---|
| Price as of 2026-08-03 close | £2.25 | $224.03 | |
| Market cap as of 2026-08-06 | n/a | $32.5B | |
| P/E as of 2026-08-06 | n/a | 21.21 | |
| PEG as of 2026-08-06 | n/a | 1.31 | |
| Net margin as of 2026-08-06 | n/a | +27.4% | |
| Gross margin as of 2026-08-06 | n/a | +61.6% | |
| Operating margin as of 2026-08-06 | n/a | +34.2% | |
| ROE as of 2026-08-06 | n/a | +24.4% | |
| ROA as of 2026-08-06 | n/a | +18.0% | |
| Debt / equity as of 2026-08-06 | n/a | 0.10 | |
| Revenue growth (YoY) as of 2026-08-06 | n/a | +10.3% | |
| Revenue CAGR (3y) SEC XBRL | n/a | +12.9% | |
| Dividend yield as of 2026-08-06 | n/a | +1.1% | |
| Dividend streak (yrs) SEC XBRL | n/a | 5 | |
| Beta as of 2026-08-06 | n/a | 0.74 | |
| 1-year return as of 2026-08-03 close | -2.4% | -21.4% | CTEC.L higher |
Fundamentals: market data, as of 2026-08-06. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-03.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.